COMMUNIQUÉS West-GlobeNewswire

Longeveron to Present at BIO International Convention 2026
04/06/2026
Company will highlight new and recently published data for stem cell therapy laromsestrocel Focus on potential partnership and strategic opportunities for Hypoplastic Left Heart Syndrome, Alzheimer’s disease, Pediatric [...]
Amneal Announces U.S. FDA Approval of Romidepsin Injection Solution
04/06/2026
Ready-to-use romidepsin formulation; offers a more convenient alternative to lyophilized powder requiring reconstitution Competitive Generic Therapy approval provides 180 days of market exclusivity and further expands [...]
NewGen Doubles Down on K25.ai with Additional US$4 Million Stake and Adopts Digital Asset Treasury Strategy
04/06/2026
NewGen's 6% Stake in K25.ai Now Valued at US$6 Million Company will Leverage Expertise of K25.ai’s Andy Cheung to Develop Digital Asset Treasury Strategy BANGKOK, June 04, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group [...]
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Eyeing Nanotech-Driven Delivery Systems, Pharmacokinetic Optimization to Advance Existing Oncology Therapies
04/06/2026
NEW YORK, June 04, 2026 (GLOBE NEWSWIRE) -- via BioMedWire -- Oncotelic Therapeutics Inc. (OTCQB: OTLC) today announces its placement in an editorial published by BioMedWire (BMW), one of 75+ brands within the Dynamic [...]
Intelligent Bio Solutions to Participate in Planet MicroCap Las Vegas Conference over June 16-18
04/06/2026
NEW YORK, June 04, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today [...]
IMUNON Announces Up to $10 Million Cash Financing
04/06/2026
Includes up-front issuance of preferred stock for $2.5 million and secured promissory notes for $7.72 million Uniquely structured, flexible financing supports IMUNON’s Highly Anticipated Phase 3 OVATION 3 Study of IMNN- [...]
Daré Bioscience Announces the Upcoming Launch of Flora Sync LF5™ Vaginal Probiotic Capsules
04/06/2026
First Product Revenue Expected This Month, Opening New Commercial Chapter for Women's Health Innovator Limited-Time Launch Offer: 30% Off + Free Shipping SAN DIEGO, June 04, 2026 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc [...]
TOMI Environmental Solutions, Inc. Scales Food Safety Presence with SteraMist Hybrid Installation at Expanded Food Facility
04/06/2026
FREDERICK, Md., June 04, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. ® (“TOMI”) (NASDAQ: TOMZ), a global leader in disinfection and decontamination solutions, announced a signed purchase order for a [...]
Melanoma Research Alliance Appoints Stephanie Kauffman as Chief Executive Officer
04/06/2026
WASHINGTON, June 04, 2026 (GLOBE NEWSWIRE) -- The Melanoma Research Alliance (MRA), the world's leading nonprofit funder of melanoma research, today announced the appointment of Stephanie Kauffman as Chief Executive [...]
RenovoRx CEO, Shaun Bagai, to Present at the iAccess Alpha Virtual Best Ideas Summer Investment Conference 2026 on June 23rd
04/06/2026
MOUNTAIN VIEW, Calif., June 04, 2026 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or “the Company”) (Nasdaq: RNXT), a life sciences company developing innovative targeted oncology therapies and commercializing [...]
Stipple Bio Enters Multi-Target License Agreement with Lonza to Advance Precision Oncology ADC Therapies
04/06/2026
– Multi-target agreement positions Stipple Bio to advance next-generation ADC therapies using Lonza’s clinically validated ADC platform — — Stipple Bio’s Pointillist Platform identifies tumor-specific cell surface [...]
America's Caregiving Dilemma: 90% Burnout, a Gen Z Reckoning, and the AI Lifeline Families Need
04/06/2026
LogicMark Survey Reveals Americans Avoiding Conversation Around Caregiving; Crisis Is Generational, Financial, and Hidden in Plain Sight LOUISVILLE, Ky., June 04, 2026 (GLOBE NEWSWIRE) -- A comprehensive new national [...]
Quoin Pharmaceuticals Announces Japan's MHLW Grants Orphan Drug Designation for QRX003 in Netherton Syndrome
04/06/2026
-Designation provides regulatory and development incentives in Japan, including up to 10 years of market exclusivity upon approval- -Follows Orphan Drug Designation, Pediatric Rare Disease Designation, and Fast Track [...]
Moleculin CEO, Walter Klemp, Highlights 45 Subject Enrollment Milestone in Recent Virtual Investor “What This Means” Segment
04/06/2026
- Access the segment here HOUSTON, June 04, 2026 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc. , (Nasdaq: MBRX) (“Moleculin” or the “Company”), today announced that Walter Klemp, Chairman and Chief Executive Officer of [...]
Free Brain Health Assessments Available During June
04/06/2026
Free Memory Screenings Offered Across the Country during Alzheimer’s and Brain Awareness Month WASHINGTON, June 04, 2026 (GLOBE NEWSWIRE) -- Alzheimer’s research sites across the country are recognizing Alzheimer’s and [...]
Scilex Holding Company (“Scilex”) Announces a Payment Date of June 15, 2026 for the Previously Announced Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities
04/06/2026
PALO ALTO, Calif., June 04, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing, and commercializing non- [...]
NXTC Announces Replay Available for Virtual KOL Event Discussing ASCO 2026 Dose Escalation Data from Phase 1 Trial of SIM0505 for Gynecologic Cancers
04/06/2026
BELTSVILLE, Md., June 04, 2026 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel therapies to treat cancer, today announced the [...]
Noom Members Kept Losing Weight a Full Year After the Program Ended, Largest-Ever Noom Randomized Clinical Trial Shows
04/06/2026
Peer-reviewed randomized controlled trial of 427 adults found that after completing Noom’s 16-week program, members continued losing weight for the next 52 weeks — reaching an average 4.1% body weight loss by week 68. [...]
Fate Therapeutics Showcases Data from FT819 and FT839 Programs at the European Congress of Rheumatology Annual Meeting
04/06/2026
FT819 off-the-shelf CAR T-cell therapy product candidate continues to broaden patient access with 21 SLE patients now treated, including as outpatient administration in community hospitals Continued demonstration of [...]

Pages